All
4 March 2021
YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders, as well as the Inclusion of the Obese Patients in the Second Arm of the Trial
YSOPIA Bioscience, a French clinical stage biotechnology company specializing in the research and development of innovative drugs using the properties of key bacterial strains...
3 March 2021
IDnow Acquires identity Trust Management AG, a Leading Identity Verification Provider in Germany
IDnow, a leading provider of Identity Verification-as-a-Service solutions, today announced that it has agreed to acquire identity Trust Management AG, a leading international...
2 March 2021
BiomX Announces Dosing of First Subject in Phase 2 Study of BX001 for Acne-Prone Skin
BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bacteria, today announced that...
25 February 2021
Izicap awarded “Best Pos/payment solution 2021” MPE AWARDS
Izicap, the european card-linked CRM & loyalty platform leader, has been awarded "Best POS/Payment Solution" by the merchant payments ecosystem organisation within their...
9 February 2021
Health for Life Capital II™ fund, managed by Seventure Partners, makes two new immuno-oncology (I/O) investments
Seventure led $10M round for new French company focusing on I/O-microbiome and provided $3M seed funding to ErVaccine, driving an increased I/O microbiome focus in fund...
27 January 2021
Proteon Pharmaceuticals and Skretting to co-develop new phage-based solutions for aquaculture
Proteon Pharmaceuticals announced a strategic partnership with Skretting aimed at providing functional solutions to tackle health challenges in the aquaculture industry. The...
26 January 2021
Isabelle de Cremoux, CEO and Managing Partner, Seventure Partners explains Why microbiota samples should be collected in all clinical trials?
In recent years, the understanding of how the microbiome and human health are linked has expanded considerably. We believe the rise in this understanding and the growing...
26 January 2021
The century of the microbiome: an exciting time for human health
While the pandemic might have caused some disruption, microbiome research hasn’t slowed down at all, notes Isabelle de Cremoux, CEO and Managing Partner, Seventure...